Oncology
Senior Consultant Surgical Oncologist – GI, Gynaecological & Peritoneal Oncology20+ Years of Experience in Surgical Oncology
HCG Cancer Center, Colaba
Mumbai
Dr. Ninad Katdare is a Senior Consultant Surgical Oncologist in Mumbai with over two decades of experience in advanced cancer surgery, particularly gastrointestinal, gynaecological and peritoneal surface malignancies.
His major areas of expertise include cancers of the stomach, colon and rectum, appendix, pancreas, liver, ovary, endometrium and cervix, along with peritoneal metastases, gastrointestinal stromal tumours, neuroendocrine tumours and abdomino-pelvic sarcomas.
Dr. Ninad Katdare completed his surgical oncology training at Tata Memorial Hospital, Mumbai and subsequently underwent advanced oncology and minimally invasive cancer surgery training at leading centres in Germany, France and Italy.
He has specialised expertise in Cytoreductive Surgery with HIPEC and Pressurized Intraperitoneal Aerosol Chemotherapy for selected patients with peritoneal surface malignancies. He is recognised for introducing PIPAC in India and has extensive experience in complex peritoneal cancer surgery.
His surgical practice also includes laparoscopic and robotic cancer surgery, fertility-preserving surgery for selected gynaecological cancers and sphincter-preserving surgery for rectal cancer.
Dr. Ninad Katdare is currently associated with HCG Cancer Centre, Colaba and Jaslok Hospital & Research Centre in Mumbai.
Cytoreductive surgery is an extensive surgical procedure used in selected patients with cancers that have spread within the abdominal or peritoneal cavity, with the goal of removing visible tumour deposits.
HIPEC delivers heated chemotherapy directly into the abdominal cavity after cytoreductive surgery in selected patients with peritoneal surface malignancies.
PIPAC delivers aerosolised chemotherapy under pressure into the abdominal cavity through minimally invasive surgery and may be considered in selected recurrent or treatment-resistant peritoneal cancers.
Stomach cancer surgery involves removal of part or all of the stomach depending on tumour location and stage, often together with regional lymph-node dissection.
Colorectal cancer surgery aims to remove the tumour and affected bowel segment while preserving bowel function whenever clinically feasible.
Sphincter-preserving rectal surgery aims to remove selected rectal tumours while avoiding a permanent stoma when oncologically and technically appropriate.
Appendiceal cancer surgery is tailored to tumour type and disease extent and may include cytoreductive surgery with HIPEC when there is selected peritoneal spread.
Pancreatic cancer surgery may involve complex procedures to remove tumours that are considered surgically resectable following multidisciplinary evaluation.
Liver cancer surgery involves removal of selected liver tumours while preserving adequate healthy liver tissue and function.
Ovarian cancer surgery may involve removal of visible tumour deposits and affected reproductive or abdominal structures as part of cytoreductive cancer treatment.
Gynaecological cancer surgery includes surgical management of cancers affecting the ovary, uterus, cervix and related pelvic structures.
Fertility-preserving surgery may be considered for carefully selected younger patients with certain early-stage gynaecological cancers when clinically appropriate.
Surgery for gastrointestinal stromal tumours aims to remove suitable tumours while preserving normal gastrointestinal function wherever possible.
Surgery may be considered for selected neuroendocrine tumours based on tumour location, extent, biological behaviour and multidisciplinary assessment.
Surgery for abdominal and retroperitoneal sarcomas often requires complex oncological resection planned according to tumour size, location and involvement of surrounding structures.
Laparoscopic cancer surgery uses minimally invasive techniques for selected tumours and may reduce incision size and recovery time while maintaining oncological principles.
Robotic-assisted surgery provides enhanced visualisation and instrument precision for selected complex oncological procedures.
MBBS, MS (General Surgery), DNB (General Surgery), Surgical Oncology Training – Tata Memorial Hospital, M.Sc Advanced Oncology – Ulm, Germany, D.U. Surgical Endoscopy – Strasbourg, France
Cytoreductive Surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC), Stomach Cancer Surgery, Colorectal Cancer Surgery, Appendiceal Cancer Surgery, Pancreatic Cancer Surgery, Liver Cancer Surgery, Ovarian Cancer Surgery, Endometrial Cancer Surgery, Cervical Cancer Surgery, Peritoneal Cancer Surgery, GIST Surgery, Neuroendocrine Tumor Surgery, Abdominal Sarcoma Surgery, Laparoscopic Cancer Surgery, Robotic Cancer Surgery, Fertility-Preserving Gynaecological Cancer Surgery, Sphincter-Preserving Rectal Surgery
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Ninad Katdare
Yes. Robotic and laparoscopic cancer surgery are among Dr. Ninad Katdare's documented areas of expertise.
Yes. His documented expertise includes stomach, colorectal, appendiceal, pancreatic and liver cancers, along with GISTs and neuroendocrine tumours.
Yes. Dr. Ninad Katdare is recognised by HCG and Jaslok as a pioneer of PIPAC in India and uses the technique for selected peritoneal cancers.
Yes. Dr. Ninad Katdare has extensive expertise in Cytoreductive Surgery with HIPEC for selected peritoneal surface malignancies.
Dr. Ninad Katdare has completed MBBS, MS and DNB in General Surgery, Surgical Oncology training at Tata Memorial Hospital, M.Sc in Advanced Oncology from Ulm, Germany and D.U. in Surgical Endoscopy from Strasbourg, France, along with advanced international oncology fellowships.
Contact us for personalized help or to schedule an appointment.